2025-11-30 from ctvnews.ca
A Halifax-based life sciences company has released the results of a promising cancer therapy study.
Sona Nanotech used a treatment called targeted hyperthermia therapy (THT) on patients with metastatic melanoma who were not responding to immunotherapy.
“We’ve taken gold nanoparticles, just nanorods, one billionth of a metre long, and inserted them into tumours and then we pass your infrared red light over them and the nanorods convert the light into heat and we use warm heat to change the core of the tumour so that it is more visible to the immune system,” explains Dr. Carman Giacomantonio.
The researcher and surgical oncologist says he’s been looking at ways to manipulate cancers for a very long time and the core of them is the problem.
Read more here